MR1 and plasma cell myeloma: An in vitro study by Gherardin et al. demonstrated that multiple myeloma (MM) cell lines express the MR1 protein and are capable of presenting vitamin B metabolites to MAIT cells isolated from healthy donors, which, in response, induce the lysis of these myeloma cells with efficiency and kinetics similar to NK cells [164].